# reload+after+2024-01-23 04:47:27.871669
address1§1025 Connecticut Avenue NW
address2§Suite 1000
city§Washington
state§DC
zip§20036
country§United States
phone§202-327-5422
website§https://60degreespharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
fullTimeEmployees§2
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Geoffrey Stuart Dow', 'age': 49, 'title': 'Chairman, CEO & President', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 54510, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Tyrone  Miller', 'age': 48, 'title': 'CFO & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 148672, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Bryan  Smith', 'age': 57, 'title': 'Chief Medical Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
priceToSalesTrailing12Months§31.864813
currency§USD
dateShortInterest§1702598400
forwardEps§-0.52
exchange§NCM
quoteType§EQUITY
shortName§60 Degrees Pharmaceuticals, Inc
longName§60 Degrees Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1689168600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ad7637e3-b301-3c55-967b-45d771706886
gmtOffSetMilliseconds§-18000000
targetHighPrice§2.4
targetLowPrice§2.4
targetMeanPrice§2.4
targetMedianPrice§2.4
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.95
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
